At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67 enrolled
Drug / intervention
Allowed drop in hemoglobin to 4.5-5.5 mmol/L +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery
In Brief
A clinical study evaluating Allowed drop in hemoglobin to 4.5-5.5 mmol/L and Allowed drop in hemoglobin to level between 5.6-6.5 mmol/L for Anemia and 3 related conditions. Completed, enrolled 67 participants across 2 sites.
Detailed Summary
The purpose of this study is to determine whether a higher threshold for transfusion with red blood cells improves the postoperative ambulation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia, Arthroplasty, Replacement, Hip
CountriesDenmark
CollaboratorsTrygFonden, Denmark
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 2009
Enrollment StartJun 2009
Primary CompletionMay 2011
Study CompletionJun 2011
TodayJul 2026
First PostedMay 21, 2009
Enrollment StartJun 1, 2009
Primary CompletionMay 1, 2011
Study CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 17.1 years ago
Interventions
Allowed drop in hemoglobin to 4.5-5.5 mmol/Lother
Transfusion with red blood cells to hemoglobin between 4.5-5.5 mmol/L (Transfusion threshold of 4.5 mmol/L)
Allowed drop in hemoglobin to level between 5.6-6.5 mmol/Lother
Transfusion with red blood cells to between hemoglobin 5.6-6.5 mmol/L (Transfusion threshold of 5.5 mmol/L)